Stephan Hirt
Overview
Explore the profile of Stephan Hirt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trum M, Riechel J, Lebek S, Pabel S, Sossalla S, Hirt S, et al.
ESC Heart Fail
. 2020 Sep;
7(6):4429-4437.
PMID: 32946200
Aims: Recent clinical trials have proven gliflozins to be cardioprotective in diabetic and non-diabetic patients. However, the underlying mechanisms are incompletely understood. A potential inhibition of cardiac Na /H exchanger...
2.
Messmann R, Dietl A, Wagner S, Domenig O, Jungbauer C, Luchner A, et al.
Mol Cell Biochem
. 2020 Jun;
472(1-2):79-94.
PMID: 32564294
Heart transplantation is often an unrealizable therapeutic option for end-stage heart failure, which is why mechanical left ventricular assist devices (LVADs) become an increasingly important therapeutic alternative. Currently, there is...
3.
Barten M, Schulz U, Beiras-Fernandez A, Berchtold-Herz M, Boeken U, Garbade J, et al.
Transplant Rev (Orlando)
. 2018 May;
32(4):207-217.
PMID: 29804793
Donor-specific antibodies (DSA) are integral to the development of antibody-mediated rejection (AMR). Chronic AMR is associated with high mortality and an increased risk for cardiac allograft vasculopathy (CAV). Anti-donor HLA...
4.
Aliabadi-Zuckermann A, Gokler J, Kaider A, Riebandt J, Moayedifar R, Osorio E, et al.
J Heart Lung Transplant
. 2018 May;
37(8):976-984.
PMID: 29802081
Background: Decision-making when offered a donor heart for transplantation is complex, and supportive data describing outcomes according to acceptance or non-acceptance choices are sparse. Our aim was to analyze donor...
5.
Schweiger M, Zuckermann A, Beiras-Fernandez A, Berchtolld-Herz M, Boeken U, Garbade J, et al.
Ann Transplant
. 2018 May;
23:322-333.
PMID: 29760372
Pediatric heart transplantation (pHTx) represents only a small proportion of cardiac transplants. Due to these low numbers, clinical data relating to induction therapy in this special population are far less...
6.
Persoon S, Paulus M, Hirt S, Jungbauer C, Dietl A, Luchner A, et al.
Heart Vessels
. 2018 Mar;
33(8):948-957.
PMID: 29546540
Implantation of left ventricular assist devices (LVADs) as bridge to transplant in end-stage heart failure allows for analyzing reverse remodeling processes of the supported heart. Whether this therapy influences the...
7.
Freundt M, Lunz D, Philipp A, Panholzer B, Lubnow M, Friedrich C, et al.
PLoS One
. 2017 Oct;
12(10):e0184995.
PMID: 29049294
Aims: Veno-arterial extracorporeal life support (ECLS) is an established method to stabilize acute circulatory failure. Parameters and data on when to ideally wean circulatory support are limited. Bilirubin is a...
8.
Camboni D, Zerdzitzki M, Hirt S, Tandler R, Weyand M, Schmid C
Interact Cardiovasc Thorac Surg
. 2016 Oct;
24(2):222-228.
PMID: 27702831
Objectives: A silicone interface at skin level of left ventricular assist device (LVAD) may reduce the risk of driveline (DL) exit site infections when compared with other materials (e.g. velour)....
9.
Barten M, Schulz U, Beiras-Fernandez A, Berchtold-Herz M, Boeken U, Garbade J, et al.
Transplant Direct
. 2016 Aug;
2(6):e81.
PMID: 27500271
There is currently no consensus regarding the dose or duration of rabbit antithymocyte globulin (rATG) induction in different types of heart transplant patients, or the timing and intensity of initial...
10.
Lehle K, Kroher J, Kolat P, von Susskind-Schwendi M, Schmid C, Haneya A, et al.
Heart Vessels
. 2015 Mar;
31(5):752-7.
PMID: 25820657
Anti-endothelial cell antibodies (AECA) may be involved in the development of heart allograft rejection. Its detection might be a cheap and noninvasive method to identify high-risk patients. An indirect immunofluorescence...